Update on the clinical use of the low-molecular-weight heparin, parnaparin

Update on the clinical use of the low-molecular-weight heparin, parnaparin

Giuseppe Camporese1, Enrico Bernardi2, Franco Noventa31Unit of Angiology and 3Department of Clinical and Experimental Medicine, Clinical Epidemiology Group, University Hospital of Padua, Italy; 2Department of Emergency and Accident Medicine, Hospital of Conegliano Veneto, ItalyAbstract: Parnaparin i...

Full description

Bibliographic Details
Main Authors:	Giuseppe Camporese, Enrico Bernardi, Franco Noventa
Format:	Article
Language:	English
Published:	Dove Medical Press 2009-09-01
Series:	Vascular Health and Risk Management
Online Access:	http://www.dovepress.com/update-on-the-clinical-use-of-the-low-molecular-weight-heparin-parnapa-a3574

Similar Items

Parnaparin: review of the literature
by: Lorenzo Pradelli
Published: (2008-03-01)

Clinical use of parnaparin in major and minor orthopedic sugery: a review
by: Stefano Bugamelli, et al.
Published: (2008-10-01)

Inhibition of trypsin by heparin and dalteparin, a low molecular weight heparin
by: Bosnić Olivera M., et al.
Published: (2009-01-01)

Inhibition of trypsin by heparin and dalteparin, a low molecular weight heparin
by: OLIVERA M. BOSNIĆ, et al.
Published: (2009-04-01)

Assessment of the Safety Profile of Unfractionated Heparin and Low Molecular Weight Heparin
by: Tair-Shin Wang, et al.
Published: (2005)

Parnaparin: confronto con le altre eparine a basso peso molecolare
by: Lorenzo Pradelli
Published: (2005-09-01)

Parnaparin: confronto con le altre eparine a basso peso molecolare
by: Lorenzo Pradelli, et al.
Published: (2004-03-01)

Rates of clinically apparent heparin-induced thrombocytopenia for unfractionated heparin vs. low molecular weight heparin in non-surgical patients are low and similar
by: Gerber Jonathan, et al.
Published: (2005-04-01)

Arterial indications for the low molecular weight heparins
by: Ageno Walter, et al.
Published: (2001-09-01)

Comparison of Low-Molecular-Weight Heparins Prepared From Ovine Heparins With Enoxaparin
by: Jianle Chen BS, et al.
Published: (2019-04-01)

IS THE INCIDENCE TREND OF HEPARIN-INDUCED THROMBOCYTOPENIA DECREASED BY THE INCREASED USE OF LOW-MOLECULAR-WEIGHT-HEPARIN?
by: Fahad Al-Eidan
Published: (2015-04-01)

Novel Experimental and Clinical Therapeutic Uses of Low-Molecular-Weight Heparin/Protamine Microparticles
by: Shingo Nakamura, et al.
Published: (2012-01-01)

Pharmacological and clinical evidence for the use of low-molecular-weight heparins in acute coronary syndromes
by: Guido Aranha Rosito, et al.
Published: (2001-08-01)

COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis
by: Alessandra F. Perna, et al.
Published: (2020-05-01)

Low-molecular-weight heparins in the treatment of venous thromboembolism
by: Huisman Menno V, et al.
Published: (2000-08-01)

Intravitreal low molecular weight heparin in PVR surgery.
by: Kumar Atul, et al.
Published: (2003-01-01)

Low-molecular-weight heparin and unfractionated heparin decrease Th-1, 2, and 17 expressions.
by: Jing-Ning Huang, et al.
Published: (2014-01-01)

Why differentiate low molecular weight heparins for venous thromboembolism?
by: Walenga Jeanine M, et al.
Published: (2007-06-01)

The potential benefits of low-molecular-weight heparins in cancer patients
by: Robert Francisco
Published: (2010-01-01)

Influence of low molecular weight heparin on cancer patients’ survival
by: V. V. Ptushkin
Published: (2014-07-01)

Influence of low molecular weight heparin on cancer patients’ survival
by: V. V. Ptushkin
Published: (2014-07-01)

The use of low molecular weight heparin Enixum® in the prevention and treatment of thrombosis in oncology
by: O V Somonova, et al.
Published: (2018-03-01)

Different Effects of Low Weight Molecular Heparin and Unfractioned Heparin on Lipid Profile and Coagulation at Haemodialysis Patients
by: Halima Resić, et al.
Published: (2010-04-01)

Potential benefits of anticoagulant doses of low molecular weight heparin in COVID-19: An observational retrospective study
by: Daniela Aschieri, et al.
Published: (2021-09-01)

The anti-factor Xa range for low molecular weight heparin thromboprophylaxis
by: Matthew Y. Wei, et al.
Published: (2015-11-01)

Mechanisms of the Antitumor Activity of Low Molecular Weight Heparins in Pancreatic Adenocarcinomas
by: Alexandros Bokas, et al.
Published: (2020-02-01)

Low Molecular Weight Heparin Nebulization Attenuates Acute Lung Injury
by: Nianlin Xie, et al.
Published: (2017-01-01)

Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin
by: Hitesh Taleja, et al.
Published: (2021-09-01)

Development of Nanoparticles as Low Molecular Weight Heparins Carriers for Oral Administration
by: Lima, Juliana Pego
Published: (2011)

Low molecular weight heparin zibor: experience of administration in surgical practice
by: M. N. Kudykin
Published: (2017-12-01)

Influence of low molecular weight heparins on immune system of surgical patients
by: O O Budnyuk, et al.
Published: (2019-02-01)

Low molecular weight heparin versus Unfractionated heparin in patients with non ST-elevation acute coronary syndrome: a randomaized clinical trial
by: Zand parsa A, et al.
Published: (2007-09-01)

Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis
by: Hind Harrak Lazrak, et al.
Published: (2017-06-01)

Iliopsoas hematoma associated with low-molecular-weight heparin use: A case report
by: Shangxiang Liu, et al.
Published: (2020-06-01)

Use of low-molecular-weight heparin in severe paraquat poisoning: a case report
by: Maria A. Montoya-Giraldo, et al.
Published: (2020-12-01)

Prevention and treatment of venous thromboembolism with low-molecular-weight heparins: Clinical implications of the recent European guidelines
by: Prandoni Paolo
Published: (2008-09-01)

Effects of low-molecular-weight heparin and unfractionated heparin on patients with exertional heat stroke with thrombocytopenia: A prospective study
by: Li Cheng, et al.
Published: (2019-01-01)

Comparison of Pregnancy Outcomes of Low Molecular Weight Heparin with Unfractionated Heparin in the Treatment of Recurrent Abortion Secondary to Antiphospholipid Syndrome
by: M Janghorbani, et al.
Published: (2013-09-01)

Low Molecular Weight Heparin Induced Skin Necrosis without Platelet Fall Revealing Immunoallergic Heparin Induced Thrombocytopenia
by: Thomas Godet, et al.
Published: (2013-01-01)

Low Molecular Weight Heparin in Portal Vein Thrombosis of Cirrhotic Patients: Only Therapeutic Purposes?
by: Raffaele Licinio, et al.
Published: (2014-01-01)